Fumarylacetoacetate hydrolase domain-containing protein 1 (FAHD1) is a mitochondrial protein that belongs to the FAH superfamily, which is characterized by the presence of a conserved FAH domain. Despite being identified as a member of this protein family, the specific biochemical functions and cellular roles of FAHD1 remain incompletely understood. However, emerging evidence suggests that FAHD1 may be involved in mitochondrial metabolism, cellular energy production, and redox homeostasis. Its localization within the mitochondria implies a role in mitochondrial function and physiology, where it may participate in enzymatic reactions, metabolic pathways, or regulatory processes crucial for maintaining cellular homeostasis. Additionally, FAHD1 has been proposed to interact with other mitochondrial proteins and regulatory factors, suggesting involvement in protein-protein interactions and signaling cascades within the mitochondrial compartment.
The activation mechanisms governing FAHD1's function are currently unclear, reflecting the limited knowledge surrounding its biochemical properties and regulatory pathways. However, activation of mitochondrial proteins typically involves a series of regulatory events that modulate protein expression, post-translational modifications, and protein-protein interactions. Transcriptional regulation of FAHD1 gene expression may occur in response to cellular stimuli or metabolic cues, leading to changes in protein levels and subsequent activation. Furthermore, post-translational modifications such as phosphorylation, acetylation, or proteolytic cleavage may regulate FAHD1's enzymatic activities, protein stability, subcellular localization, or interactions with binding partners, thereby influencing its functional state within the mitochondria. Additionally, activation of FAHD1 may be modulated by cellular signaling pathways, metabolic flux, or environmental factors, further regulating its participation in mitochondrial processes and cellular physiology. Further investigation is warranted to elucidate the specific mechanisms governing FAHD1 activation and its role in mitochondrial metabolism and cellular function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
NAD+, Free Acid | 53-84-9 | sc-208084B sc-208084 sc-208084A sc-208084C sc-208084D sc-208084E sc-208084F | 1 g 5 g 10 g 25 g 100 g 1 kg 5 kg | $57.00 $191.00 $302.00 $450.00 $1800.00 $3570.00 $10710.00 | 4 | |
NAD+ is a coenzyme that plays a crucial role in redox reactions. It enhances FAHD1 by participating in the catalytic process, since FAHD1 is a mitochondrial enzyme that hydrolyzes NAD+-metabolites. | ||||||
Calcium chloride anhydrous | 10043-52-4 | sc-207392 sc-207392A | 100 g 500 g | $66.00 $262.00 | 1 | |
Calcium chloride can increase the intracellular calcium concentration. Since the FAHD1 protein is found in mitochondria, a rise in calcium can indirectly enhance the metabolic activity of mitochondria, and thereby FAHD1. | ||||||
Pyruvic acid | 127-17-3 | sc-208191 sc-208191A | 25 g 100 g | $41.00 $96.00 | ||
Pyruvate is a key intersection in several metabolic pathways. As FAHD1 participates in the tricarboxylic acid cycle (TCA), the increased presence of pyruvate can stimulate this cycle and indirectly enhance the activity of FAHD1. | ||||||
Coenzyme A | 85-61-0 anhydrous | sc-211123 sc-211123A sc-211123B sc-211123C | 10 mg 25 mg 100 mg 250 mg | $83.00 $135.00 $418.00 $801.00 | 1 | |
Coenzyme A is involved in the synthesis and oxidation of fatty acids, and the oxidation of pyruvate in the TCA cycle. Its increase can lead to enhanced activity of FAHD1, which is involved in the TCA cycle. | ||||||
Oxaloacetic Acid | 328-42-7 | sc-279934 sc-279934A sc-279934B | 25 g 100 g 1 kg | $306.00 $963.00 $7980.00 | 1 | |
Oxaloacetate is one of the key metabolites in the TCA cycle. Increased oxaloacetate levels can enhance FAHD1 activity by promoting TCA cycle turnover. | ||||||
Citric Acid, Anhydrous | 77-92-9 | sc-211113 sc-211113A sc-211113B sc-211113C sc-211113D | 500 g 1 kg 5 kg 10 kg 25 kg | $50.00 $110.00 $145.00 $248.00 $598.00 | 1 | |
Citrate is a key compound in the TCA cycle. Its increase can enhance the activity of FAHD1, which is involved in the TCA cycle. | ||||||
Acetic acid | 64-19-7 | sc-214462 sc-214462A | 500 ml 2.5 L | $63.00 $106.00 | 5 | |
Acetate is a key component in the TCA cycle. Increased acetate can indirectly enhance the activity of FAHD1 by promoting TCA cycle turnover. | ||||||
Malic acid | 6915-15-7 | sc-257687 | 100 g | $130.00 | 2 | |
Malate is a key intermediate in the TCA cycle. An increase in malate can enhance FAHD1 activity by promoting TCA cycle turnover. | ||||||
α-Ketoglutaric Acid | 328-50-7 | sc-208504 sc-208504A sc-208504B sc-208504C sc-208504D sc-208504E sc-208504F | 25 g 100 g 250 g 500 g 1 kg 5 kg 16 kg | $33.00 $43.00 $63.00 $110.00 $188.00 $738.00 $2091.00 | 2 | |
α-Ketoglutarate is one of the key metabolites in the TCA cycle. Increased α-Ketoglutarate levels can enhance FAHD1 activity by promoting TCA cycle turnover. | ||||||
Fumaric acid | 110-17-8 | sc-250031 sc-250031A sc-250031B sc-250031C | 25 g 100 g 500 g 2.5 kg | $43.00 $57.00 $114.00 $228.00 | ||
Fumarate is a key intermediate in the TCA cycle. An increase in fumarate can enhance FAHD1 activity by promoting TCA cycle turnover. | ||||||